The upregulation of HHIP-AS1 in T-ALL compared to AML is confirmed by the differential expression analysis pointing out a significant and consistent upregulation of all the T-ALL lncRNA biomarker candidates (Fig. 4C). This evidence concerns the gene HHIP and acute myeloid leukemia.